🇺🇸 FDA

Intelligence Platform

Patents

Browse 140 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11357842

PD-L1 targeting DNA vaccine for cancer immunotherapy

Vaximm AG · Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11351276

Radiopharmaceutical compositions of radioactive halogenated benzylguanidine

Jubilant Draximage Inc. · Granted Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11229700

Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibi

Ludwig-Maximilians-Universitat Munchen · Granted Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11206824

Gas delivery device comprising a gas releasing molecule and a gas permeable membrane

Julius-Maximilians-Universitat Wurzburg · Granted Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11180518

Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma

Ludwig-Maximilians-Universitat Munchen · Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11161873

Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

Ludwig-Maximilians-Universitat Munchen · Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11149073

ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains

Julius-Maximilians-Universitat Wurzburg · Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11104708

Articles comprising a silk polypeptide for antigen delivery

Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11028144

Soluble glycoprotein V for treating thrombotic diseases

Julius-Maximilians-Universitat Wurzburg · Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11000579

Recombinant Eimeria maxima protein delivered as nanoparticles

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10980868

VEGFR-2 targeting immunotherapy approach

Vaximm AG · Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10941200

TREM2 cleavage modulators and uses thereof

Ludwig-Maximilians-Universitat Munchen · Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10905752

VEGFR-2 targeting DNA vaccine for combination therapy

Vaximm AG · Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10821163

Process for the production of a DNA vaccine for cancer immunotherapy

Vaximm AG · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10822378

Mutated structural protein of a parvovirus

Ludwig-Maximilians-Universitat Munchen · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815455

Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1

Vaximm AG · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10781251

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Julius-Maximilians-Universitat Wurzburg · Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10663473

Method of identifying a status of a mucosal intestinal epithelial barrier to improve treat

Maximus Diagnostic Technologies LLC · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633451

Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

Ludwig-Maximilians-Universitat Munchen · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10604565

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof f

Julius-Maximilians-Universitat Wurzburg · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10543190

Suppositories comprising cannabinoids

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10513532

Compound containing dexpanthenol

Julius-Maximilians-Universitat Wurzburg · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10441552

Anti-microbial composition comprising cannabinoids

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10441645

MSLN targeting DNA vaccine for cancer immunotherapy

Vaximm AG · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted